Drug Development

Michelle Hoffman, editorial director of Pharmaceutical Technology.

Articles

Pharma companies could benefit from the lessons learned in this fall's financial crisis.

Quality Counts

Sophisticated excipient development, especially for coatings, is staying on top of new challenges and meeting expanding industry needs.

A Fresh Coat: Innovation in Excipients

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Pharmaceutical Technology will feature video coverage of AAPS this month.

Bringing AAPS to You

Also, Maxygen looks to costs, jobs; Receptor BioLogix appoints Dale R. Pfost CEO; more...

Company and People Notes: Avid Bioservices Signs Manufacturing Supply Pact with Catalyst Biosciences; Pfizer Named Mace L. Rothenberg Senior VP of Development for its Oncology Unit, More...

Also, MedImmune opens Cambridge, UK, facility and makes reverse engineering pact with Omninvest; BD Medicine appoints Carol Adiletto VP of clinical and regulatory affairs; more...

Company and People Notes: Novartis to Acquire Nektar Drug Delivery Unit; LifeCycle Pharma Appoints Jim New As President and CEO; More...

Also, Millipore opens new membrane-casting manufacturing facility in Ireland; Surface Logix appoints Keith Dionne president, CEO, and a member of the board; more...

Company and People Notes: DSM Anti-Infectives to Close Strangnas, Sweden, Site; A-Bio Names Steven S. Lee CEO; More...

John Dingell (D-MI), chairman of the US House Committee on Energy and Commerce and Bart Stupak (D-MI), chairman of that committee's Subcomittee on Oversight and Investigations, directed a letter to US Food and Drug Administration Commissioner Andrew C. von Eschenbach to request further information regarding FDA's process for inspecting manufacturing facilities of the generic drug manufacturer Actavis following several product recalls by the company.

Congress Probes FDA's Inspection Process of Actavis

A bill that would require country-of-origin labeling for active and inactive ingredients for all prescription and over-the-counter pharmaceuticals was introduced in the US Senate last week.

Senate Introduces Bill for Country-Of-Origin Labeling for Pharmaceutical Ingredients

Also, Merck & Co. discontinues development of its obesity drug taranabant; Synthetech names Frederic Farkas director of manufacturing; more...

Company and People Notes: Azopharma Expands Analytical Lab; Inotek Pharma Appoints Paul G. Howes President, CEO, and Director; More...

The European Fine Chemicals Group (EFCG) and the International Pharmaceutical Excipents Council of Europe (IPEC Europe) announced the formation of  a European Pharmaceutical Excipients Certification Project to develop advocacy and stakeholder management in Europe and to give advice to two European working teams as part of an effort to develop a certification program for manufacturers and distributors of pharmaceutical excipients.